FFAR3 and polycystic ovary syndrome: This evidence suggests that the ameliorative effect of DOP on PCOS rats is mainly due to promoting the release of butyrate by gut microbiota, which affects the secretion of sex hormones through the butyrate-GPR41-PYY mechanism, rather than DOP itself.